JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 6 No. 8 582-587
© 1965 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tothill, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tothill, P.

The Retention by the Body of 131I-Polyvinylpyrrolidone and its Effect on Radiation Dose

P. Tothill, B.Sc., Ph.D., A.Inst.P.1

Edinburgh, Scotland

ABSTRACT

It is shown that following the intravenous injection of PVP-131I, approximately half the material is excreted in the urine in the first 24 hours, while the remaining half is retained for a long time, mainly in the liver. The resulting rediation dose may be quite high when amounts required for brain scanning are administered. The use of the biological half-life to assess radiation dose is shown to be misleading under the circumstances described.

FOOTNOTES

1 Department of Medical Physics, The Royal Infirmary, Edinburgh 3, Scotland.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1965 by the Society of Nuclear Medicine.